影像学检查在前列腺癌骨转移诊断中的研究进展
Research Progress of Imaging Examination in the Diagnosis of Bone Metastasis of Prostate Cancer
摘要: 前列腺癌(PCa)是全球男性除肺癌之外的第二大常见的恶性肿瘤，同时也是我国中老年男性最常见的恶性肿瘤之一，骨转移是其常见的并发症之一，骨转移导致的骨相关不良事件(SREs)严重影响患者的生活质量和预后，且我国患者相对而言大部分发现较晚，多数患者已出现骨转移等并发症，故早期发现并诊断出前列腺癌，对患者的治疗、生活质量及预后等具有重大影响。现阶段影像学检查因其经济、简便与无创等优势在前列腺癌的应用中备受重视，影像学检查主要包括超声检查、X线、计算机断层扫描(CT)、核磁共振成像(MRI)、单光子发射断层扫描(SPECT/CT)及PET/CT扫描，本文就以上检查方法的目前研究进展进行综述。
Abstract: Prostate cancer (PCa) is the second most common malignant tumor in men worldwide except lung cancer, and it is also one of the most common malignant tumors in middle-aged and elderly men in China. Bone metastasis is one of the common complications, and bone-related adverse events (SREs) caused by bone metastasis seriously affect the quality of life and prognosis of patients, and the majority of patients in China are relatively late detected, and most of the patients have already suffered from complications such as bone metastasis. Therefore, early detection and diagnosis of prostate cancer has a significant impact on patients’ treatment, quality of life and prognosis. At the present stage, imaging examination is highly valued in the application of prostate cancer because of its advantages of economy, simplicity and non-invasiveness, etc. Imaging examination mainly includes ultrasonography, X-ray, computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPECT/CT), and PET/CT scanning, and this paper reviews the current research progress of the above methods.
文章引用：李松璋, 黄敏玉, 付小金. 影像学检查在前列腺癌骨转移诊断中的研究进展[J]. 临床医学进展, 2024, 14(12): 249-257. https://doi.org/10.12677/acm.2024.14123073

参考文献

[1] 潘剑, 朱耀, 戴波, 等. 2022年度前列腺癌基础研究及临床诊疗新进展[J]. 中国癌症杂志, 2023, 33(3): 210-217.
[2] 李宁, 肖国有. 前列腺癌骨转移治疗的研究进展[J]. 肿瘤防治研究, 2020, 47(8): 641-646.
[3] Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. [Google Scholar] [CrossRef] [PubMed]
[4] Huang, J., Shen, J., Li, X., Rengan, R., Silvestris, N., Wang, M., et al. (2020) Incidence of Patients with Bone Metastases at Diagnosis of Solid Tumors in Adults: A Large Population-Based Study. Annals of Translational Medicine, 8, 482-482. [Google Scholar] [CrossRef] [PubMed]
[5] Lee, J., Park, S.H., Koh, S., Lee, S.H., Kim, Y.J., Choi, Y.J., et al. (2014) Effectiveness and Safety of Cabazitaxel plus Prednisolone Chemotherapy for Metastatic Castration-Resistant Prostatic Carcinoma: Data on Korean Patients Obtained by the Cabazitaxel Compassionate-Use Program. Cancer Chemotherapy and Pharmacology, 74, 1005-1013. [Google Scholar] [CrossRef] [PubMed]
[6] Schalk, S.G., Demi, L., Bouhouch, N., Kuenen, M.P.J., Postema, A.W., de la Rosette, J.J.M.C.H., et al. (2017) Contrast-enhanced Ultrasound Angiogenesis Imaging by Mutual Information Analysis for Prostate Cancer Localization. IEEE Transactions on Biomedical Engineering, 64, 661-670. [Google Scholar] [CrossRef] [PubMed]
[7] 程丹. 经直肠彩色多普勒超声诊断前列腺癌的临床价值研究[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(84): 267-268.
[8] 崔凌煦. 经直肠前列腺超声造影参数与血清外泌体浓度在前列腺癌中的诊断价值[D]: [硕士学位论文]. 呼和浩特: 内蒙古医科大学, 2023.
[9] 吴春梅, 李思琪, 杨存霞, 等. mpMRI影像组学在前列腺癌诊疗中的研究进展[J]. 磁共振成像, 2023, 14(6): 166-170.
[10] 徐姜南. mpMRI阴性患者诊断有临床意义前列腺癌的危险因素分析与风险分层[D]: [硕士学位论文]. 苏州: 苏州大学, 2022.
[11] 王欢, 于慕渊. 多参数磁共振成像-经直肠超声认知融合在前列腺穿刺活检中的应用价值分析[J]. 影像研究与医学应用, 2023, 7(23): 188-190.
[12] 袁昆, 王国寿. CT、磁共振成像和DR在鉴别良恶性脊柱骨折中的应用价值分析[J]. 中国实用医药, 2020, 15(36): 87-88.
[13] Turpin, A., Girard, E., Baillet, C., Pasquier, D., Olivier, J., Villers, A., et al. (2020) Imaging for Metastasis in Prostate Cancer: A Review of the Literature. Frontiers in Oncology, 10, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
[14] Padhani, A.R., Lecouvet, F.E., Tunariu, N., Koh, D., De Keyzer, F., Collins, D.J., et al. (2017) Metastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body Magnetic Resonance Imaging-Based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer. European Urology, 71, 81-92. [Google Scholar] [CrossRef] [PubMed]
[15] 周长友, 陈久尊, 何家维, 等. 四肢骨转移瘤的影像学分析[J]. 实用放射学杂志, 2013, 29(11): 1823-1825, 1843.
[16] Gong, X., Tao, Y., Wang, R., Liu, N., Huang, X., Zheng, J., et al. (2021) Application of Diffusion Weighted Imaging in Prostate Cancer Bone Metastasis: Detection and Therapy Evaluation. Anti-Cancer Agents in Medicinal Chemistry, 21, 1950-1956. [Google Scholar] [CrossRef] [PubMed]
[17] 景国东. 3.0TMR多种新技术在前列腺癌诊断的临床价值[D]: [硕士学位论文]. 重庆: 第二军医大学, 2014.
[18] Dwivedi, D.K. and Jagannathan, N.R. (2022) Emerging MR Methods for Improved Diagnosis of Prostate Cancer by Multiparametric MRI. Magnetic Resonance Materials in Physics, Biology and Medicine, 35, 587-608. [Google Scholar] [CrossRef] [PubMed]
[19] Li, M., Guo, J., Hu, P., Jiang, H., Chen, J., Hu, J., et al. (2021) Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI. Radiology, 299, 362-370. [Google Scholar] [CrossRef] [PubMed]
[20] Chatterjee, A., Harmath, C. and Oto, A. (2020) New Prostate MRI Techniques and Sequences. Abdominal Radiology, 45, 4052-4062. [Google Scholar] [CrossRef] [PubMed]
[21] Ketelsen, D., Röthke, M., Aschoff, P., et al. (2008) Detection of Bone Metastasis of Prostate Cancer—Comparison of Whole-Body MRI and Bone Scintigraphy. Rofo, 180, 746-752.
[22] Chen, R., Yang, Q., Chen, W., Yang, Y., Cheng, C., Sun, Y., et al. (2021) Whole-Body MRI-Based Multivariate Prediction Model in the Assessment of Bone Metastasis in Prostate Cancer. World Journal of Urology, 39, 2937-2943. [Google Scholar] [CrossRef] [PubMed]
[23] Abou Heidar, N., El-Doueihi, R., Merhe, A., Ramia, P., Bustros, G., Yacoubian, A., et al. (2021) The Role of Pre-Biopsy mpMRI in Lymph Node Staging for Prostate Cancer. Urologia Journal, 89, 64-69. [Google Scholar] [CrossRef] [PubMed]
[24] Arslan, A., Karaarslan, E., Güner, A.L., Sağlıcan, Y., Tuna, M.B. and Kural, A.R. (2022) Comparing the Diagnostic Performance of Multiparametric Prostate MRI versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension. Academic Radiology, 29, 698-704. [Google Scholar] [CrossRef] [PubMed]
[25] 南方护骨联盟前列腺癌骨转移专家组, 陈东, 樊卫, 等. 前列腺癌骨转移诊疗专家共识(2023版) [J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(3): 201-208.
[26] Even-Sapir, E., Metser, U., Mishani, E., et al. (2006) The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single-and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT. Journal of Nuclear Medicine, 47, 287-297.
[27] 陆海健, 周勇, 林红萍, 等. 99mTc-MDP SPECT/CT显像定量分析对前列腺癌骨转移的诊断价值以及SUV的一致性研究[J]. 浙江医学, 2023, 45(11): 1152-1156.
[28] 闫君, 常雁荣, 李险峰. 99mTc-MDP SPECT/CT定量分析预测前列腺癌单发骨转移的价值[J]. 山西医科大学学报, 2022, 53(8): 965-968.
[29] 翟威豪, 何薇. SPECT/CT骨定量SUVmax分析在老年前列腺癌骨转移中的鉴别诊断价值[J]. 分子影像学杂志, 2021, 44(6): 983-987.
[30] Pomykala, K.L., Czernin, J., Grogan, T.R., Armstrong, W.R., Williams, J. and Calais, J. (2019) Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines. Journal of Nuclear Medicine, 61, 405-411. [Google Scholar] [CrossRef] [PubMed]
[31] Fanti, S., Goffin, K., Hadaschik, B.A., Herrmann, K., Maurer, T., MacLennan, S., et al. (2020) Consensus Statements on PSMA PET/CT Response Assessment Criteria in Prostate Cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 469-476. [Google Scholar] [CrossRef] [PubMed]
[32] Zhou, J., Gou, Z., Wu, R., Yuan, Y., Yu, G. and Zhao, Y. (2019) Comparison of PSMA-PET/CT, Choline-Pet/CT, Naf-Pet/CT, MRI, and Bone Scintigraphy in the Diagnosis of Bone Metastases in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis. Skeletal Radiology, 48, 1915-1924. [Google Scholar] [CrossRef] [PubMed]
[33] Bénard, F., Harsini, S., Wilson, D., Zukotynski, K., Abikhzer, G., Turcotte, E., et al. (2022) Intra-Individual Comparison of 18F-Sodium Fluoride PET-CT and 99mTC Bone Scintigraphy with SPECT in Patients with Prostate Cancer or Breast Cancer at High Risk for Skeletal Metastases (MITNEC-A1): A Multicentre, Phase 3 Trial. The Lancet Oncology, 23, 1499-1507. [Google Scholar] [CrossRef] [PubMed]
[34] Yoon, J., Ballas, L., Desai, B. and Jadvar, H. (2017) Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting 18F-Sodium Fluoride Positron Emission Tomography-Computed Tomography Positivity for First Bone Metastases in Patients with Biochemical Recurrence after Radical Prostatectomy. World Journal of Nuclear Medicine, 16, 229-236. [Google Scholar] [CrossRef] [PubMed]
[35] Cohen, D., Hazut Krauthammer, S., Fahoum, I., Kesler, M. and Even-Sapir, E. (2023) PET Radiotracers for Whole-Body in Vivo Molecular Imaging of Prostatic Neuroendocrine Malignancies. European Radiology, 33, 6502-6512. [Google Scholar] [CrossRef] [PubMed]
[36] Roberts, M.J., Maurer, T., Perera, M., Eiber, M., Hope, T.A., Ost, P., et al. (2022) Using PSMA Imaging for Prognostication in Localized and Advanced Prostate Cancer. Nature Reviews Urology, 20, 23-47. [Google Scholar] [CrossRef] [PubMed]
[37] Maurer, T., Eiber, M., Schwaiger, M. and Gschwend, J.E. (2016) Current Use of PSMA-PET in Prostate Cancer Management. Nature Reviews Urology, 13, 226-235. [Google Scholar] [CrossRef] [PubMed]
[38] Daniels, H., Gilbert, R. and Bonin, L. (2023) The Diagnostic Accuracy of 68Ga-PSMA PET/CT versus 99mTC-MDP Bone Scintigraphy for Identifying Bone Metastases in Persons with Prostate Cancer: A Systematic Review. Journal of Medical Imaging and Radiation Sciences, 54, 545-555. [Google Scholar] [CrossRef] [PubMed]
[39] 彭静. 18F-PSMA-1007 PET/CT与99mTc-MDP全身骨显像诊断前列腺癌根治术后疑诊进展患者骨转移的对比研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2022.
[40] Riola-Parada, C., García-Cañamaque, L., Pérez-Dueñas, V., Garcerant-Tafur, M. and Carreras-Delgado, J.L. (2016) Simultaneous PET/MRI vs. PET/CT in Oncology. A Systematic Review. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 35, 306-312. [Google Scholar] [CrossRef] 

为你推荐